(1)
Identification of RUNX1 and IFNGR2 As Prognostic-Related Biomarkers Correlated With Immune Infiltration and Subtype Differentiation of Low-Grade Glioma. Biomol Biomed 2023, 23 (3), 405–425. https://doi.org/10.17305/bjbms.2022.8086.